On 3 September 2024, Sunshine SwissCo AG, a consortium led by EQT, the Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., announced the completion of an accelerated bookbuilding process targeting professional investors in Switzerland and qualified investors internationally. This process resulted in the placement of 14,273,859 shares in Galderma Group AG at a price of CHF 75 per share, generating approximately CHF 1.07 billion in proceeds.

Following the placement, the Sellers will retain a 61.21% stake in Galderma’s share capital, with EQT’s representation on the Board of Directors remaining unchanged.